Your browser doesn't support javascript.
loading
LEF1 supports metastatic brain colonization by regulating glutathione metabolism and increasing ROS resistance in breast cancer.
Blazquez, Raquel; Rietkötter, Eva; Wenske, Britta; Wlochowitz, Darius; Sparrer, Daniela; Vollmer, Elena; Müller, Gunnar; Seegerer, Julia; Sun, Xueni; Dettmer, Katja; Barrantes-Freer, Alonso; Stange, Lena; Utpatel, Kirsten; Bleckmann, Annalen; Treiber, Hannes; Bohnenberger, Hanibal; Lenz, Christof; Schulz, Matthias; Reimelt, Christian; Hackl, Christina; Grade, Marian; Büyüktas, Deram; Siam, Laila; Balkenhol, Marko; Stadelmann, Christine; Kube, Dieter; Krahn, Michael P; Proescholdt, Martin A; Riemenschneider, Markus J; Evert, Matthias; Oefner, Peter J; Klein, Chistoph A; Hanisch, Uwe K; Binder, Claudia; Pukrop, Tobias.
Afiliación
  • Blazquez R; Department of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Rietkötter E; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Wenske B; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Wlochowitz D; Department of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Sparrer D; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Vollmer E; Institute of Medical Bioinformatics, University Medical Center Göttingen, Georg August University, Göttingen, Germany.
  • Müller G; Department of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Seegerer J; Department of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Sun X; Department of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Dettmer K; Department of Internal Medicine III, Hematology and Medical Oncology, University Hospital Regensburg, Regensburg, Germany.
  • Barrantes-Freer A; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
  • Stange L; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
  • Utpatel K; Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
  • Bleckmann A; Department of Neuropathology, University Medical Center Leipzig, Leipzig, Germany.
  • Treiber H; Department of Neuropathology, University Hospital Regensburg, Regensburg, Germany.
  • Bohnenberger H; Institute of Pathology, University of Regensburg, Regensburg, Germany.
  • Lenz C; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Schulz M; Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany.
  • Reimelt C; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Hackl C; Max Planck Institute of Experimental Medicine, Göttingen, Germany.
  • Grade M; Institute of Pathology, University Medical Center Göttingen, Göttingen, Germany.
  • Büyüktas D; Institute of Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany.
  • Siam L; Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
  • Balkenhol M; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Stadelmann C; Experimental Medicine and Therapy Research, University of Regensburg, Regensburg, Germany.
  • Kube D; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Krahn MP; Department of General, Visceral and Pediatric Surgery, University Medical Center Göttingen, Göttingen, Germany.
  • Proescholdt MA; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Riemenschneider MJ; Department of Neurosurgery, University Medical Center Göttingen, Göttingen, Germany.
  • Evert M; Comprehensive Cancer Center, University Medical Center Göttingen, Göttingen, Germany.
  • Oefner PJ; Institute of Neuropathology, University Medical Center Göttingen, Göttingen, Germany.
  • Klein CA; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Hanisch UK; Internal Medicine D, University Hospital Münster, Münster, Germany.
  • Binder C; Department of Neurosurgery, University Hospital Regensburg, Regensburg, Germany.
  • Pukrop T; Department of Neuropathology, University Hospital Regensburg, Regensburg, Germany.
Int J Cancer ; 146(11): 3170-3183, 2020 06 01.
Article en En | MEDLINE | ID: mdl-31626715
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias de la Mama / Especies Reactivas de Oxígeno / Factor de Unión 1 al Potenciador Linfoide / Glutatión Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias de la Mama / Especies Reactivas de Oxígeno / Factor de Unión 1 al Potenciador Linfoide / Glutatión Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Int J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Estados Unidos